Pharmacological and behavioral treatment for trichotillomania: An updated systematic review with meta-analysis.
N-acetylcysteine
TTM
clinical trials
habit-reversal training
meta-analysis
olanzapine
selective serotonin reuptake inhibitors
Journal
Depression and anxiety
ISSN: 1520-6394
Titre abrégé: Depress Anxiety
Pays: United States
ID NLM: 9708816
Informations de publication
Date de publication:
08 2020
08 2020
Historique:
received:
30
12
2019
revised:
01
04
2020
accepted:
19
04
2020
pubmed:
12
5
2020
medline:
1
1
2021
entrez:
12
5
2020
Statut:
ppublish
Résumé
Trichotillomania (TTM) is a difficult-to-treat psychiatric condition with no first-line medications approved by the Food and Drug Administration. Individuals with TTM often feel that clinicians know little about this disorder. Here, we present an updated meta-analysis of randomized controlled trials (RCTs) examining treatments for TTM. Pubmed, PsychINFO, Embase, and CENTRAL were searched with the terms "Trichotillomania OR Hair Pulling Disorder" to identify randomized controlled clinical trials evaluating treatments for TTM. Twenty-four trials involving 26 comparisons and 857 participants were included in this meta-analysis. Behavioral therapy with habit-reversal training components (BT-HRT) demonstrated a large benefit compared to control conditions (standardized mean difference [SMD] [95% CI] = -1.22 [-1.71, -0.73], p < .0001) for improving TTM symptoms. Clomipramine (SMD [95% CI] = -0.71 [-1.38, -0.05], p = .036), N-acetylcysteine (SMD [95% CI] = -0.75 [-1.36, -0.13], p = .017) and olanzapine (SMD [95% CI] = -0.94 [-1.77, -0.12], p = .025) demonstrated significant benefits compared to placebo in RCTs. BT-HRT has demonstrated the largest treatment effects and has the strongest evidence base for reducing TTM symptoms. In contrast, several pharmacological agents have demonstrated efficacy in single randomized clinical trials that would benefit from replication. Additional trials are needed to identify other effective medications for TTM and determine the relative efficacy of available agents.
Sections du résumé
BACKGROUND
Trichotillomania (TTM) is a difficult-to-treat psychiatric condition with no first-line medications approved by the Food and Drug Administration. Individuals with TTM often feel that clinicians know little about this disorder. Here, we present an updated meta-analysis of randomized controlled trials (RCTs) examining treatments for TTM.
METHODS
Pubmed, PsychINFO, Embase, and CENTRAL were searched with the terms "Trichotillomania OR Hair Pulling Disorder" to identify randomized controlled clinical trials evaluating treatments for TTM.
RESULTS
Twenty-four trials involving 26 comparisons and 857 participants were included in this meta-analysis. Behavioral therapy with habit-reversal training components (BT-HRT) demonstrated a large benefit compared to control conditions (standardized mean difference [SMD] [95% CI] = -1.22 [-1.71, -0.73], p < .0001) for improving TTM symptoms. Clomipramine (SMD [95% CI] = -0.71 [-1.38, -0.05], p = .036), N-acetylcysteine (SMD [95% CI] = -0.75 [-1.36, -0.13], p = .017) and olanzapine (SMD [95% CI] = -0.94 [-1.77, -0.12], p = .025) demonstrated significant benefits compared to placebo in RCTs.
CONCLUSIONS
BT-HRT has demonstrated the largest treatment effects and has the strongest evidence base for reducing TTM symptoms. In contrast, several pharmacological agents have demonstrated efficacy in single randomized clinical trials that would benefit from replication. Additional trials are needed to identify other effective medications for TTM and determine the relative efficacy of available agents.
Substances chimiques
Serotonin Uptake Inhibitors
0
Clomipramine
NUV44L116D
Acetylcysteine
WYQ7N0BPYC
Types de publication
Journal Article
Meta-Analysis
Review
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
715-727Informations de copyright
© 2020 Wiley Periodicals LLC.
Références
Azrin, N. H., & Nunn, R. G. (1973). Habit-reversal: A method of eliminating nervous habits and tics. Behaviour Research and Therapy, 11(4), 619-628.
Bloch, M. H. (2009). Trichotillomania across the life span. Journal of the American Academy of Child and Adolescent Psychiatry, 48(9), 879-883. https://doi.org/10.1097/CHI.0b013e3181ae09f3
Bloch, M. H., Landeros-Weisenberger, A., Dombrowski, P., Kelmendi, B., Wegner, R., Nudel, J., … Coric, V. (2007). Systematic review: Pharmacological and behavioral treatment for trichotillomania. Biological Psychiatry, 62(8), 839-846. https://doi.org/10.1016/j.biopsych.2007.05.019
Bloch, M. H., Panza, K. E., Grant, J. E., Pittenger, C., & Leckman, J. F. (2013). N-Acetylcysteine in the treatment of pediatric trichotillomania: A randomized, double-blind, placebo-controlled add-on trial. Journal of the American Academy of Child and Adolescent Psychiatry, 52(3), 231-240. https://doi.org/10.1016/j.jaac.2012.12.020
Cameron, I. M., Reid, I. C., & MacGillivray, S. A. (2014). Efficacy and tolerability of antidepressants for sub-threshold depression and for mild major depressive disorder. Journal of Affective Disorders, 166, 48-58. https://doi.org/10.1016/j.jad.2014.04.078
Christenson, G. A., Mackenzie, T. B., & Mitchell, J. E. (1991a). Characteristics of 60 adult chronic hair pullers. American Journal of Psychiatry, 148(3), 365-370. https://doi.org/10.1176/ajp.148.3.365
Christenson, G. A., Mackenzie, T. B., Mitchell, J. E., & Callies, A. L. (1991b). A placebo-controlled, double-blind crossover study of fluoxetine in trichotillomania. American Journal of Psychiatry, 148(11), 1566-1571. https://doi.org/10.1176/ajp.148.11.1566
Cipriani, A., Furujawa, T. A., Salanti, G., Chaimani, A., Atkinson, L. Z., Ogawa, Y., … Geddes, J. R. (2018). Compartive efficacy and acceptability of 21 antidepressant drugs for the actue treatment of adults with major depressive disorder: A systematic review and network network meta-analysis. Lancet, 391(10128), 1357-1366. https://doi.org/10.1016/S0140-6736(17)32802-7
Conley, R. R., & Meltzer, H. Y. (2000). Adverse events related to olanzapine. Journal of Clinical Psychiatry, 61(Suppl 8), 26-30. https://www.ncbi.nlm.nih.gov/pubmed/10811240
Cortese, S., Aadamo, N., Del Giovane, C., Mohr-Jensen, C., Hayes, A. J., Carucci, S., … Cipriani, A. (2018). Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents and adults: A systematic review and network meta-analysis. Lancet Pychiatry, 5(9), 727-738. https://doi.org/10.1016/S2215-0366(18)30269-4
Diefenbach, G. J., Tolin, D. F., Hannan, S., Crocetto, J., & Worhunsky, P. (2005). Trichotillomania: Impact on psychosocial functioning and quality of life. Behaviour Research and Therapy, 43(7), 869-884. https://doi.org/10.1016/j.brat.2004.06.010
Diefenbach, G. J., Tolin, D. F., Hannan, S., Maltby, N., & Crocetto, J. (2006). Group treatment for trichotillomania: Behavior therapy versus supportive therapy. Behavior Therapy, 37(4), 353-363.
Dougherty, D. D., Loh, R., Jenike, M. A., & Keuthen, N. J. (2006). Single modality versus dual modality treatment for trichotillomania: Sertraline, behavioral therapy, or both? Journal of Clinical Psychiatry, 67(7), 1086-1092.
Faraone, S. V. (2008). Interpreting estimates of treatment effects: Implications for managed care. P & T, 33(12), 700-711. https://www.ncbi.nlm.nih.gov/pubmed/19750051
Farhat, L. C., Olfson, E., Levine, J. L. S., Li, F., Franklin, M. E., Lee, H. J., … Bloch, M. H. (2019). Measuring treatment response in pediatric trichotillomania: A meta-analysis of clinical trials. Journal of Child and Adolescent Psychopharmacology, https://doi.org/10.1089/cap.2019.0103. [published online ahead of print December 2, 2019].
Farhat, L. C., Olfson, E., Li, F., Telang, S., & Bloch, M. H. (2018). Identifying standardized definitions of treatment response in trichotillomania: A meta-analysis. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 89, 446-455. https://doi.org/10.1016/j.pnpbp.2018.10.009
Franklin, M. E., Edson, A. L., Ledley, D. A., & Cahill, S. P. (2011a). Behavior therapy for pediatric trichotillomania: A randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry, 50(8), 763-771. https://doi.org/10.1016/j.jaac.2011.05.009
Franklin, M. E., Zagrabbe, K., & Benavides, K. L. (2011b). Trichotillomania and its treatment: A review and recommendations. Expert review of neurotherapeutics, 11(8), 1165-1174. https://doi.org/10.1586/ern.11.93
Grant, J. E., & Chamberlain, S. R. (2016). Trichotillomania. American Journal of Psychiatry, 173(9), 868-874. https://doi.org/10.1176/appi.ajp.2016.15111432
Grant, J. E., Odlaug, B. L., & Kim, S. W. (2009). N-acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: A double-blind, placebo-controlled study. Archives of General Psychiatry, 66(7), 756-763. https://doi.org/10.1001/archgenpsychiatry.2009.60
Grant, J. E., Odlaug, B. L., Schreiber, L. R., & Kim, S. W. (2014). The opiate antagonist, naltrexone, in the treatment of trichotillomania: Results of a double-blind, placebo-controlled study. Journal of Clinical Psychopharmacology, 34(1), 134-138. https://doi.org/10.1097/jcp.0000000000000037
Grant, J. E., Redden, S. A., & Chamberlain, S. R. (2019). Milk thistle treatment for children and adults with trichotillomania: A double-blind, placebo-controlled, crossover negative study. Journal of Clinical Psychopharmacology, 39(2), 129-134.
Grant, J. E., Redden, S. A., Leppink, E. W., & Chamberlain, S. R. (2017). Trichotillomania and co-occurring anxiety. Comprehensive Psychiatry, 72, 1-5. https://doi.org/10.1016/j.comppsych.2016.09.005
Grant, J. E., Redden, S. A., Medeiros, G. C., Odlaug, B. L., Curley, E. E., Tavares, H., & Keuthen, N. J. (2017). Trichotillomania and its clinical relationship to depression and anxiety. International Journal of Psychiatry in Clinical Practice, 21(4), 302-306. https://doi.org/10.1080/13651501.2017.1314509
Houghton, D. C., Maas, J., Twohig, M. P., Saunders, S., Compton, S. N., Neal-Barnett, A., … Woods, D. W. (2016). Comorbidity and quality of life in adults with hair pulling disorder. Psychiatry Research, 239, 12-19. https://doi.org/10.1016/j.psychres.2016.02.063
Keuthen, N. J., Rothbaum, B. O., Fama, J., Altenburger, E., Falkenstein, M. J., Sprich, S. E., … Welch, S. S. (2012). DBT-enhanced cognitive-behavioral treatment for trichotillomania: A randomized controlled trial. Journal of Behavioral Addictions, 1(3), 106-114. https://doi.org/10.1556/jba.1.2012.003
Lee, E. B., Haeger, J. A., Levin, M. E., Ong, C. W., & Twohig, M. P. (2018). Telepsychotherapy for trichotillomania: A randomized controlled trial of ACT enhanced behavior therapy. Journal of Obsessive-Compulsive and Related Disorders, 18, 106-115. https://doi.org/10.1016/j.jocrd.2018.04.003
Lee, E. B., Homan, K. J., Morrison, K. L., Ong, C. W., Levin, M. E., & Twohig, M. P. (2020). Acceptance and commitment therapy for trichotillomania: A randomized controlled trial of adults and adolescents. Behavior Modification, 44(1), 70-91. https://doi.org/10.1177/0145445518794366
Lee, H. J., Espil, F. M., Bauer, C. C., Siwiec, S. G., & Woods, D. W. (2018). Computerized response inhibition training for children with trichotillomania. Psychiatry Research, 262, 20-27. https://doi.org/10.1016/j.psychres.2017.12.070
Liu, C., Kanazawa, T., Tian, Y., Mohamed Saini, S., Mancuso, S., Mostaid, M. S., … Bousman, C. (2019). The schizophrenia genetics knowledgebase: A comprehensive update of findings from candidate gene studies. Translational Psychiatry, 9(1), 205. https://doi.org/10.1038/s41398-019-0532-4
Maas, J., Keijsers, G. P. J., Rinck, M., & Becker, E. S. (2018). Does cognitive bias modification prior to standard brief cognitive behavior therapy reduce relapse rates in hair pulling disorder? A double-blind randomized controlled trial. Journal of Social and Clinical Psychology, 37(6), 453-479. https://doi.org/10.1521/jscp.2018.37.6.453
McGuire, J. F., Ung, D., Selles, R. R., Rahman, O., Lewin, A. B., Murphy, T. K., & Storch, E. A. (2014). Treating trichotillomania: A meta-analysis of treatment effects and moderators for behavior therapy and serotonin reuptake inhibitors. Journal of Psychiatric Research, 58, 76-83. https://doi.org/10.1016/j.jpsychires.2014.07.015
Ninan, P. T., Rothbaum, B. O., Marsteller, F. A., Knight, B. T., & Eccard, M. B. (2000). A placebo-controlled trial of cognitive-behavioral therapy and clomipramine in trichotillomania. Journal of Clinical Psychiatry, 61(1), 47-50.
O'Sullivan, R. L., Keuthen, N. J., Christenson, G. A., Mansueto, C. S., Stein, D. J., & Swedo, S. E. (1997). Trichotillomania: Behavioral symptom or clinical syndrome? American Journal of Psychiatry, 154(10), 1442-1449. https://doi.org/10.1176/ajp.154.10.1442
Panza, K. E., Pittenger, C., & Bloch, M. H. (2013). Age and gender correlates of pulling in pediatric trichotillomania. Journal of the American Academy of Child and Adolescent Psychiatry, 52(3), 241-249. https://doi.org/10.1016/j.jaac.2012.12.019
Pittenger, C., & Bloch, M. H. (2014). Pharmacological treatment of obsessive-compulsive disorder. Psychiatric Clinics of North America, 37(3), 375-391. https://doi.org/10.1016/j.psc.2014.05.006
Pollard, C. A., Ibe, I. O., Krojanker, D. N., Kitchen, A. D., Bronson, S. S., & Flynn, T. M. (1991). Clomipramine treatment of trichotillomania: A follow-up report on four cases. Journal of Clinical Psychiatry, 52(3), 128-130.
Rahman, O., McGuire, J., Storch, E. A., & Lewin, A. B. (2017). Preliminary randomized controlled trial of habit reversal training for treatment of hair pulling in youth. Journal of Child and Adolescent Psychopharmacology, 27(2), 132-139. https://doi.org/10.1089/cap.2016.0085
Rogers, K., Banis, M., Falkenstein, M. J., Malloy, E. J., McDonough, L., Nelson, S. O., … Haaga, D. A. F. (2014). Stepped care in the treatment of trichotillomania. Journal of Consulting and Clinical Psychology, 82(2), 361-367. https://doi.org/10.1037/a0035744
Shareh, H. (2018). A preliminary investigation of metacognitive therapy and habit reversal as a treatment for trichotillomania. Behavioural and Cognitive Psychotherapy, 46(1), 1-20. https://doi.org/10.1017/S1352465817000546
Slikboer, R., Nedeljkovic, M., Bowe, S. J., & Moulding, R. (2017). A systematic review and meta-analysis of behaviourally based psychological interventions and pharmacological interventions for trichotillomania. Clinical Psychologist, 21(1), 20-32. https://doi.org/10.1111/cp.12160
Streichenwein, S. M., & Thornby, J. I. (1995). A long-term, double-blind, placebo-controlled crossover trial of the efficacy of fluoxetine for trichotillomania. American Journal of Psychiatry, 152(8), 1192-1196. https://doi.org/10.1176/ajp.152.8.1192
Swedo, S. E., Lenane, M. C., & Leonard, H. L. (1993). Long-term treatment of trichotillomania (hair pulling). New England Journal of Medicine, 329(2), 141-142. https://doi.org/10.1056/nejm199307083290220
Swedo, S. E., Leonard, H. L., Rapoport, J. L., Lenane, M. C., Goldberger, E. L., & Cheslow, D. L. (1989). A double-blind comparison of clomipramine and desipramine in the treatment of trichotillomania (hair pulling). New England Journal of Medicine, 321(8), 497-501. https://doi.org/10.1056/nejm198908243210803
Toledo, E. L., De Togni Muniz, E., Brito, A. M., de Abreu, C. N., & Tavares, H. (2015). Group treatment for trichotillomania: Cognitive-behavioral therapy versus supportive therapy. Journal of Clinical Psychiatry, 76(4), 447-455. https://doi.org/10.4088/JCP.13m08964
Van Ameringen, M., Mancini, C., Patterson, B., Bennett, M., & Oakman, J. (2010). A randomized, double-blind, placebo-controlled trial of olanzapine in the treatment of trichotillomania. Journal of Clinical Psychiatry, 71(10), 1336-1343. https://doi.org/10.4088/JCP.09m05114gre
van Minnen, A., Hoogduin, K. A., Keijsers, G. P., Hellenbrand, I., & Hendriks, G. J. (2003). Treatment of trichotillomania with behavioral therapy or fluoxetine: A randomized, waiting-list controlled study. Archives of General Psychiatry, 60(5), 517-522. https://doi.org/10.1001/archpsyc.60.5.517
Viechtbauer, W., & Cheung, M. W. L. (2010). Outlier and influence diagnostics for meta-analysis. Research Synthesis Methods, 1(2), 112-125. https://doi.org/10.1002/jrsm.11
Weidt, S., Klaghofer, R., Kuenburg, A., Bruehl, A. B., Delsignore, A., Moritz, S., & Rufer, M. (2015). Internet-based self-help for trichotillomania: A randomized controlled study comparing decoupling and progressive muscle relaxation. Psychother and Psychosom, 84(6), 359-367.
Woods, D. W., Flessner, C. A., Franklin, M. E., Keuthen, N. J., Goodwin, R. D., Stein, D. J., & Walther, M. R. (2006a). The Trichotillomania Impact Project (TIP): Exploring phenomenology, functional impairment, and treatment utilization. Journal of Clinical Psychiatry, 67(12), 1877-1888.
Woods, D. W., & Houghton, D. C. (2014). Diagnosis, evaluation, and management of trichotillomania. Psychiatric Clinics of North America, 37(3), 301-317. https://doi.org/10.1016/j.psc.2014.05.005
Woods, D. W., Wetterneck, C. T., & Flessner, C. A. (2006b). A controlled evaluation of acceptance and commitment therapy plus habit reversal for trichotillomania. Behaviour Research and Therapy, 44(5), 639-656. https://doi.org/10.1016/j.brat.2005.05.006